Regenxbio (RGNX) Other Non-Current Liabilities (2015 - 2026)
Regenxbio's Other Non-Current Liabilities was $486,000 in Q2 2026, down 26.8% from $664,000 a year earlier.
Powered by 
Analysis
Regenxbio (RGNX) Other Non-Current Liabilities (2015 - 2026) Analysis & Trends
At the end of FY2025, Other Non-Current Liabilities at Regenxbio came in at $638,000, down 82.4% from FY2024.
- Other Non-Current Liabilities has now declined for five consecutive years, with a five-year compound annual growth rate of -67.4% (FY2020 to FY2025).
- In earlier years, Other Non-Current Liabilities was $3.64 million in FY2024 (-91.6%), $43.49 million in FY2023 (-51.1%), $89.01 million in FY2022 (-33.3%) and $133.46 million in FY2021 (-23.5%).
- The Q2 2026 figure marks the lowest quarterly Other Non-Current Liabilities since Q4 2015.
- Across the past five years, year-over-year decline in Other Non-Current Liabilities ran from 23.5% in Q4 2021 to 98.4% in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Regenxbio | 407.85 Mn | -525.24 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 486,000.00 |
| Dec 31, 2025 | 638,000.00 |
| Sep 30, 2025 | 648,000.00 |
| Jun 30, 2025 | 664,000.00 |
| Mar 31, 2025 | 11.12 Mn |
| Dec 31, 2024 | 3.64 Mn |
| Sep 30, 2024 | 35.05 Mn |
| Jun 30, 2024 | 41.08 Mn |
| Mar 31, 2024 | 44.70 Mn |
| Dec 31, 2023 | 43.49 Mn |
| Sep 30, 2023 | 53.10 Mn |
| Jun 30, 2023 | 67.38 Mn |
| Mar 31, 2023 | 77.38 Mn |
| Dec 31, 2022 | 89.01 Mn |
| Sep 30, 2022 | 103.08 Mn |
| Jun 30, 2022 | 114.17 Mn |
| Mar 31, 2022 | 122.51 Mn |
| Dec 31, 2021 | 133.46 Mn |
| Sep 30, 2021 | 144.32 Mn |
| Jun 30, 2021 | 151.08 Mn |
API Access
Regenxbio Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();